Vanda Pharmaceuticals (VNDA) files $200M mixed shelf
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) has filed $200,000,000 mixed shelf of:
Preferred Stock
Common Stock
Debt Securities
Warrants
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- Workday launches AI research team and PhD fellowship program
- Essity to buy Kenvue's feminine care brands in Brazil for $284m
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
